Asymmetry of sympathetic activity in a rat model of Parkinson's disease induced by 6-hydroxydopamine: haemodynamic, electrocardiographic and biochemical changes

被引:9
作者
Turgut, M
Jellestad, FK
Mathisen, JR
Thorsen, T
Wester, K
Aakvag, A
机构
[1] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway
[2] Univ Bergen, Inst Physiol Psychol, N-5000 Bergen, Norway
[3] Univ Bergen, Inst Clin Biol, N-5021 Bergen, Norway
关键词
Parkinson's disease; substantia nigra; behaviour; sympathetic activity; 6-hydroxydopamine; rat;
D O I
10.1007/s004330050077
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We studied the effects of experimental hemiparkinsonism upon sympathetic function in rat. The rats were divided into three groups: a group given intact control, one given lesioning with 6-hydroxydopamine (6-OHDA), and one given sham operation. One day after apomorphine testing following lesioning of the substantia nigra (SN) with 6-OHDA, heart rate (HR), mean arterial blood pressure (MAP), and electrocardiogram (EGG) were monitored. Plasma norepinephrine (NE), epinephrine (E), and dopamine (DA) levels were measured. Thereafter, immunohistochemical examination was performed to detect the extent of 6-OHDA lesions, using the avidinbiotinylated peroxidase complex (ABC) method. There was no difference in the total number of tyrosine hydroxylase (TH)-positive cells and rotation responses between the right- and left-sided 6-OHDA-treated groups. On the other hand, injury of rats with unilateral 6-OHDA resulted in haemodynamic, electrocardiographic, and biochemical changes. A significant difference was found between the right-sided 6-OHDA-treated rats and the left-sided treated ones. The MAP increased in the group given left 6-OHDA treatment and to lesser extent in the sham-operated group. In contrast, MAP did not increase in the group given right 6-OHDA treatment and was significantly lower than values in both the intact control rats and the sham-treated rats. Also, only the group given right 6-OHDA injury showed a fall in the value of HR. The plasma NE level was significantly decreased in the group given right 6-OHDA treatment compared with all other groups (P < 0.005). Our results indicate that right-sided lesioning of the nigrostriatal DA pathway in the central nervous system (CNS) has greater sympathetic consequences than left-sided ones. These results also suggest that there is a differential effect of right-sided SN lesions on sympathetic cardiac innervation. The mechanism behind the confronting impairment of autonomic nervous system (ANS) could in this experiment be attributable to an asymmetric representation of sympathetic function in the brain. However, further studies will be needed before final conclusions can be made.
引用
收藏
页码:281 / 292
页数:12
相关论文
共 50 条
  • [21] Neuroprotective and Antiapoptotic Potential of Trigonelline in a Striatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease
    M. Mirzaie
    M. Khalili
    Z. Kiasalari
    M. Roghani
    Neurophysiology, 2016, 48 : 176 - 183
  • [22] Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease
    Maia, Serge
    Arlicot, Nicolas
    Vierron, Emilie
    Bodard, Sylvie
    Vergote, Jackie
    Guilloteau, Denis
    Chalon, Sylvie
    SYNAPSE, 2012, 66 (07) : 573 - 583
  • [23] Characterization of a new low-dose 6-hydroxydopamine model of Parkinson's disease in rat
    Penttinen, Anna-Maija
    Suleymanova, Ilida
    Albert, Katrina
    Anttila, Jenni
    Voutilainen, Merja H.
    Airavaara, Mikko
    JOURNAL OF NEUROSCIENCE RESEARCH, 2016, 94 (04) : 318 - 328
  • [24] Depletion of brain glutathione potentiates the effect of 6-hydroxydopamine in a rat model of Parkinson's disease
    García, JC
    Remires, D
    Leiva, A
    González, R
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2000, 14 (03) : 147 - 153
  • [25] Depletion of brain glutathione potentiates the effect of 6-hydroxydopamine in a rat model of Parkinson’s disease
    Julio C. García
    Diadelis Remires
    Aida Leiva
    Ricardo González
    Journal of Molecular Neuroscience, 2000, 14 : 147 - 153
  • [26] Exercise-Induced Neuroprotection in the 6-Hydroxydopamine Parkinson’s Disease Model
    Zeinab Rezaee
    Sayed Mohammad Marandi
    Hojjatallah Alaei
    Fahimeh Esfarjani
    Neurotoxicity Research, 2020, 38 : 850 - 858
  • [27] Transcriptome profiling of five brain regions in a 6-hydroxydopamine rat model of Parkinson's disease
    Lyu, Ying
    Huang, Yiying
    Shi, Guiying
    Lei, Xuepei
    Li, Keya
    Zhou, Ran
    Bai, Lin
    Qin, Chuan
    CNS NEUROSCIENCE & THERAPEUTICS, 2021, 27 (11) : 1289 - 1299
  • [28] Neuroprotective and Antiapoptotic Potential of Trigonelline in a Striatal 6-Hydroxydopamine Rat Model of Parkinson's Disease
    Mirzaie, M.
    Khalili, M.
    Kiasalari, Z.
    Roghani, M.
    NEUROPHYSIOLOGY, 2016, 48 (03) : 176 - 183
  • [29] Exercise-Induced Neuroprotection in the 6-Hydroxydopamine Parkinson's Disease Model
    Rezaee, Zeinab
    Marandi, Sayed Mohammad
    Alaei, Hojjatallah
    Esfarjani, Fahimeh
    NEUROTOXICITY RESEARCH, 2020, 38 (04) : 850 - 858
  • [30] Cognitive-Enhancing Effect of Quercetin in a Rat Model of Parkinson's Disease Induced by 6-Hydroxydopamine
    Sriraksa, Napatr
    Wattanathorn, Jintanaporn
    Muchimapura, Supaporn
    Tiamkao, Somsak
    Brown, Kamoltip
    Chaisiwamongkol, Kowit
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012 : 1 - 9